Linezolid Teva

Linezolid, the active ingredient in Linezolid Teva, is an oxazolidinone presented as an oral tablet for oral use. It treats infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE).

GNH USA supplies Linezolid Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, transparent documentation, and responsive technical support throughout the procurement process.

Linezolid is indicated for infections caused by Gram‑positive bacteria and is used in several clinical contexts. - Methicillin‑resistant Staphylococcus aureus (MRSA): effective treatment of skin, soft‑tissue and respiratory infections caused by MRSA. - Vancomycin‑resistant Enterococcus (VRE): provides an oral option for infections where vancomycin is ineffective. - Community‑acquired bacterial pneumonia: improves outcomes in adult patients with pneumonia due to susceptible organisms. - Skin and soft‑tissue infections: resolves cellulitis, abscesses and wound infections caused by susceptible Gram‑positive pathogens. - Infections caused by susceptible Gram‑positive bacteria: broad coverage for streptococci and other susceptible organisms.

Linezolid may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools. - Headache: transient cranial discomfort. - Metallic taste: altered taste perception.

Serious or Rare Side Effects: - Myelosuppression: decreased blood cell production, including anemia or thrombocytopenia. - Peripheral neuropathy: nerve damage causing tingling or numbness. - Lactic acidosis: rare metabolic disturbance with elevated lactate levels.

When prescribing Linezolid, clinicians should consider several safety precautions to minimize risk. - Monitor blood counts: perform baseline and periodic CBC to detect myelosuppression. - Assess renal and hepatic function: adjust therapy if significant impairment is present. - Avoid concomitant serotonergic agents: risk of serotonin syndrome. - Counsel patients on diet: limit tyramine‑rich foods to prevent hypertensive reactions. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Linezolid interacts with several drug classes; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic drugs: may precipitate serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis with tyramine.

Moderate Interactions (Monitor Closely): - Rifampicin: induces hepatic enzymes, reducing linezolid plasma levels. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Ethanol: potentiates central nervous system depression, advise caution.